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Background: Misoprostol  is a
pros tag land in  ana logue w i th
uterotonic properties. Administered
orally or vaginally, it is an effective
agent for induction of first trimester
abortions.
Aim: To establish the effectiveness
and complications arising within the
f i rs t  week fo l low ing  the
administration of Misoprostol for
termination of pregnancy (TOP) in
the first trimester of pregnancy.
Setting: A regional hospital in the
Helderberg basin of the greater
Cape Town area, serving both as
district and secondary hospital.
Methods: Prospective descriptive
study of patients using Misoprostol
as  induc t ion  agent  in  the  f i rs t
trimester of pregnancy. Success rate,
side effects and complications were
monitored over three visits, up until
one week after termination
R e s u l t s :  1 0 5  p a t i e n t s  w e r e
enrolled into the study. Following
the intake of Misoprostol, T0%
reported a successful  induct ion
within 48 hours. The evacuation
of the uterus was found to be
uncomplicated in 64% oI these
patients. g% received a repeat dose
of Misoprostol,3% required a third
medical induction. In I patientwith
a n  u n s u c c e s s f u l  i n d u c t i o n ,  a n
ectopic pregnancy was diagnosed. In
4 women the uterus had been
surgically perforated, without need
for further surgeD/.
C o n c l u s i o n :  T h e  u s e  o f
Misoprostol for the induction of
termination of pregnancy in the first
trimester proved to be effective and
acceptably safe.
Abstract
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Introduct ion
I n  m o s t  d e v e l o p i n g  c o u n t r i e s
abo r t i on  cons t i t u tes  an  imoor tan t
p u b l i c  h e a l t h  p r o b l e m .  l l l e g a l l y
i n d u c e d  a b o r t i o n s  u n d e r  u n s a f e
c o n d i t i o n s  a r e  i m p o r t a n t
contr ibutors to maternal  morbid i ty
a n d  m o r t a l i t y ,  p a r t i c u l a r l y  i n
developing countr ies,  which do not
h a v e  t h e  r e s o u r c e s  t o  m a n a g e
abort ion-re lated compl icat ions.  r '  2
In countr ies where ear ly  abor t ions
are legal  and avai lable on demand and
s a f e ,  m a t e r n a l  m o r b i d i t y  a n d
mortality have decreased significantly.
I n  t he  Un i ted  K ingdom,  t he  1985 -
1 9 8 7  r e p o r t  o n  C o n f i d e n t i a l
E n q u i r i e s  i n t o  M a t e r n a l  D e a t h s
reco rded ,  t ha t  f o r  t he  f i  r s t  t ime
abort ions no longer contr ibuted to
maternal mortality.3
D u r i n g  1 9 9 7 ,  S o u t h  A f r i c a
i n t r o d u c e d  n e w  l e g i s l a t i o n
lega l i s i ng  t e rm ina t i on  o f  p regnancy
on  demand  (Cho i ce  onTerm ina t i on
o f  P regnancy  Ac t ,  Ac t  No .92  o f
1996) .4 (see Table l ,  over  poge)
First trimester abortions are supposed
to be handled at the district hospital
l e v e l  i n  S o u t h  A f r i c a .  T h i s
responsib i l i ty ,  though,  was shi f ted to
some seconda ry  hosp i t a l s  due  to
widespread staf f  res is tance.  Only
l imi ted numbers of  terminat ions of
p regnanc ies  (TOP)  a re  p resen t l y
ca r r i ed  ou t  ou ts ide  the  te r t i a r y
hospitals of the Western Cape.s
-Table I: Choice onTermination of Pregnancy Act (Act No.92 of 1996).
. Section2.( | ):Apregnancy may be terminated---
(a) Upon request of a woman during the first twelve weeks of the gestation period of her pregnancy
Counsel l ing
. 4.The State shall promote the provision of non-mandatory and non- directive counselling, before and after
the termination of a pregnancy.
Consent
. 5.( l) Subject o the provision of sub sections (4) and (5),the termination may only take place with the informed
consent ofthe pregnant woman.
. (2)Notwith standing any other law or the common law, but subject to the provisions of subsections (4) and (5),
no consent other than that of the pregnant woman shall be required for the termination of a pregnancy.
. (3): in the case of a pregnant minor, a medical practitioner or a registered midwife, as the case may be , shall
advise such minor to consult with her parents, guardian, family members or friends before the pregnancy is
terminated. Provided that the termination of pregnancy shall not be denied because such minor chooses not
to consult them.
By using Misoprosto l  the medical
induction of termination of pregnancy
can be init iated by the patient herself
at home,followed by an easier surgical
evacuation (after the patients aborts)
in the day theatre. ln the South African
context  th is  is  cheaper and more
Dractical. The alternative would be a
s u r g i c a l  t e r m i n a t i o n  r e q u i r i n g
admission. a formal anaesthetic and
surgical dilatation and cu rettage, which
is more traumatic for the patient and
the medical staff involved.
Misoprostol, (methyl I l , | 6-dihydroxy-
| 6-methyl-9-oxoprost- | 3E-en- | -oate)
is a prostaglandin EI analogue,that has
been used for several years for the
p reven t i on  o f  non -s te ro ida l  an t i -
in f lammatory drug- induced gastr ic
ulcers.6'7 Reported adverse effects have
b e e n  m a i n l y  o b s e r v e d  i n  t h e
gastro intest inal  t ract ,  dose re lated
ranging from mild abdominal cramps to
diarrhoea, less frequently constipation,
n a u s e a  a n d  v o m i t i n g .  l t  i s
contraindicated in pregnancy, because
its intake causes uterine contractions
and may cause uterine bleeding and
misca r r i age .s  O the r  advan tages  o f
Misoprostol include: (a) No need for
refrigerating; (b) Low cost ( | Rand per
tablet);and (c) Easyto administer (orally
or vaginally)
Literature about the effect of Misoprostol
used on its own to induce abortion in
the first or second trimesters is limited.e
Local experience from secondary level
hospitals in South Africa is lacking, but
international experience from other
developing countries is promising.r0'r I
At the time of the study, Misoprostol
was not yet registered in South Africa
for the use of termination of pregnancy
(TOP), but clinical trials were allowed
with special permission.This tudy was
pe r fo rmed  as  an  ex tens ion  o f  an
approved clinical trial of the use of
Misoprostol at Tygerberg Hospital, to
evaluate the effectiveness and safety of
M i s o p r o s t o l  i n  t e r m i n a t i o n  o f
pregnancy in first trimesterTOPs
The study set t ing was Hot tentots
Ho l l and  Hosp i t a l  (HHH) ,  s i t ua ted  a t
S o m e r s e t  W e s t  i n  t h e  W e s t e r n
Cape Province of  South Afr ica.  l t
se rves  as  a  d i s t r i c t  hosp i t a l  f o r  a
c o m m u n i t y  o f  a b o u t  1 4 0  0 0 0
p e o p l e  a n d  a l s o  f u n c t i o n s  a s  a
s e c o n d a r y  l e v e l  c e n t r e  f o r  t h e
He lde rbe rg  and  Ove rbe rg  reg ion .
Methods
T h e  d e s i g n  w a s  a  p r o s p e c t i v e ,
d e s c r i p t i v e  s t u d y ,  c a r r i e d  o u t
be tween  I  December  1997  and  3  |
D e c e m b e r  1 9 9 8 .  T h e  p r i n c i p a l
r e s e a r c h e r  c a r r i e d  o u t  t h e
sc reen ing  p rocess ,  p re -p rocedu ra l
counse l l i ng ,  t he  ac tua l  p rocedu re
and  the  fo l l ow  up .
A l l  w o m e n  w h o  r e q u e s t e d
te rm ina t i on  o f  p regnancy  i n  t he
hospital during the study period were
referred to the researcher.They were
evaluated clinically and by ultrasound
fo r  ges ta t i ona l  age  and  fo r  t he i r
gene ra l  med ica l  and  psycho log i ca l
condition. Only women with a first
trimester pregnancy of less than l2
completed weeks qual i f ied for  th is
study.
At the first visit, blood was taken for
Haemoglobin andVDRL A pre-procedural
counselling session was part ofthis firstvisit
Once admitted to the study,the patient
received 4 tablea of Misoprostol (200mcg
per tablet) with the instruction to take 2
tablets (400mcg) oralty the same day.The
other 2 tablets had to be inserted vaginally
24 hours lateri f no bleeding had occurred.
The patient was instructed to report back
to the hospital 48 hours after the first
visit. following an overnight fast for the
surgical procedure (vacuum aspiration).
lf the patient did not report any bleeding
or the passing of products during this
pe r i od ,  t he  who le  p rocedu re  was
repeated. lf this medical induction with
Misoprostol failed three times,the patient
had a surgical termination by dilatation
and curettage 48 to 72 hours after the
failed last attempt.
Before the su rgical evacuation, patients
were asked about  the possib le s ide
ef fects of  the medicat ion,  vaginal
bleeding and the passing of products
of conception. lf the patient had bled
or had passed products ofconception,
a suct ion curet tage (vabra)  under
a n a e s t h e t i c  ( e i t h e r  g e n e r a l  o r
neuroleptic with Ketamine I mg per
kg,  Fentanyl  |  00ug and Droper idol
lOmg) was performed.
Following the procedure, the patient was
asked to report back for a final follow-up
visit one week later:This final visit was used
to oomine the uterus with uhrasound, and
to control for any intra-operative or post-
operative complications.
Ethical aspects:
All patients gave their written consent
to participate in the study after the
i n i t i a l  c o u n s e l l i n g .  T h e  e t h i c s
committee at Tygerberg Hospital and
the  Resea rch  Commi t t ee  o f  t he
University of Stellenbosch approved
the study.
Results
l. Potients: 105 patients requesting
TOP qualified for the study. Only two
patients requested a repeatToP
Ethnicity:
Most women (6 | %) were of mixed ethnic
origin ("Coloured"),2l% were Black and
l8%White.
Education:
Seventy percent QA%) had a scholastic
level of Grade of l0 (St.8) or higher.
Age:
The youngest woman requesting TOP
was | 3 year old, the oldest 40 years old,
whilst he majority were between l6 and
25 years old (50%). (See Figure l)
Reason for request of termination:
40 women (38%) had a combination of
financial and psychological problems,
fo l lowed by  36  (34%)  w i th  on ly
psycho log ica l ,  and 28  (27%)  w i th
financial reasons only. Only one request
was based on an existing medical risk
factor for the mother - she developed
kidney failure in her previous pregnancy.
Employment and marital status:
Only 26 (25%) women were unem-
ployed at the time of the request,whilst
85 (8l%) were not married.
Parity:Almost half of the women were
Primagravida (46%), whilst l87o were
Parity | (See Figure ll,overleof)
Contracept ion:  64 (6 l%) women
did not use any kind of contraception
p r i o r  t o  c o n c e p t i o n .  O f  t h o s e
women who had used contraception
before conception more than 60%
(25) were on the p i l l ,  but  admit ted
to sk ipping tablets.
2.Effectiveness ond comPlications:
O f  t he  105  pa t i en t s ,  100  re tu rned
fo r  t he  evacua t i on  p rocedu re  48
h o u r s  a f t e r  a d m i n i s t r a t i o n  o f
M isop ros to l .  O f  t he  f i ve  5  t ha t  d id
n o t  r e t u r n ,  o n e  d e c i d e d  t o
c o n t i n u e  w i t h  t h e  p r e g n a n c y ,  a
s e c o n d  c h a n g e d  h e r  m i n d  a f t e r
t a k i n g  M i s o p r o s t o l  d u e  t o  t h e
p ressu re  f r om he r  boy f r i end  and
Figure I:Age profile of women reguestingTOP
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Figure II: Pority in different ethnic grouqs of women reguestingTOP
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i n  sp i te  o f  the  r i sk  invo lved.  No
in fo rmat ion  cou ld  be  ob ta ined o f
the  remain ing  th ree .
The 100 women who continued with the
protocol reported the following possible
side effects of Misoprostol:
.  3 0  e x p e r i e n c e d  c r a m p i n g
abdominal pains. 4a% Q0) of
Pr imagrav idas  nd  l8% (10)  o f
Multigravidas experienced cramping
abdominal pains (P<0.0l)
. 24 felt some nausea
. | | experienced a combination of
c ramping  abdomina l  pa ins  and
nausea
. 8 had vomited
. 7 developed iarrhoea
Outcorne:
. 87 of the 100 women had theTOP
performed at the return visit 48
hours after taking Misoprostol. Of
them 83 (95%)  repor ted  a
successful medical induction with
Misoprostol manifested by vaginal
bleeding and passing of products. | 7
(20%) took only 2 Misoprostol
tablets.
. | 2 of the | 00 women had to take a
second dose of Misoprostol with
the procedure following 48 hours
later.  In 7 the second induct ion
Number of patients
was successful.Three of the latter
group had a third medical induction
w i t h  M i s o p r o s t o l ,  w i t h  t h e
procedure done72 hours later. In 2
o f  t h e m  t h e  i n d u c t i o n  w a s
successful.
. The one patient initially changed her
mind and did not continue with the
evacuation, but did so 6 weeks
later.46 (45%) TOP's were
performed under general anaesthetic.
56  (55%)  pa t i en t s  rece i ved  a
neurolept ic  anaesthet ic . l5  (15%)
patients asked for sterilisation at the
first visit, l3 of which were done at
the same time and 2 were given a
separate appointment. The average
hospital stay after the procedure was
4 hours.
Complications
ln one pat ient  wi th an unsuccessfu l
induct ion,  an ectopic pregnancy was
diagnosed.
ln 4 (4%) women, the uterus was
p e r f o r a t e d  d u r i n g  t h e  s u r g i c a l
e v a c u a t i o n  w i t h o u t  f u r t h e r
comp l i ca t i ons .  One  o f  t he  4  women
w a s  a d m i t t e d  f o r  o b s e r v a t i o n
ove rn igh t  and  d i scha rged  i n  a  good
c o n d i t i o n  t h e  n e x t  m o r n i n g .
None  o f  t he  100  women  requ i red
b l o o d  t r a n s f u s i o n .  N o
comp l i ca t i ons  rega rd ing  re ta ined
p r o d u c t s ,  i n f e c t i o n  o r  n e e d  f o r
r e p e a t e d  c u r e t t a g e  w e r e
observed.
In take  o f  M isop ros to l  t ab le t s
. Multigravidas used an average of4.5
tablets,and
Primagravidas4.0.tablets (P>0.0 | )
. Primagravidas took an average of
2.36 tablets orally and 1.68 tablets
vaginally, whilst Multigravidas took
an average of 2.35 tablets orally and
2. l7 tablets vaginal ly . (P =0.024)
. The maximum number of tablets
used by one patient was 12, whilst
the min imum number of  tablets
u s e d  b y  o n e  p a t i e n t  w a s  2 .
The last visit one week later
Only 43 (42%) patients came for a follow-
up visit one-week after the surgical
procedure. Of these women 26 (60%)
experienced a small post-operative
bleeding and l3 (30%) had moderate to
heavy bleeding. | | (26%) were sti l l
bleeding at the time of the visit.
15 (35%) had already started with a
contraceptive after the TOB of whom 9
(21%) had Depo-Provera and 6 women
( l4%) went on oral contraception. 28
(65%) still had to arrange an appointment
at the family planning clinic.
This study reports on the experience
with a relat ively smal l  number (100)
of terminations of pregnancy induced
by the intake of Misoprostol ,  in a
distr ict / regional hospital  sett ing in
South Africa.
The most important aspects of note
in the pat ient sample were: ( l )  the
d i f f e r e n c e s  i n  t h e  p a r i t y  s t a t u s
between the ethnic groups (coloured
and white - lower parity, and black
more multiparity); (2) the very high
failure rate (24%) of the contraceptive
pi l l  as result  of  poor compl iance;and,
a s  c o u l d  b e  e x p e c t e d ,  t h e  m o s t
common reason given for the choice
of termination of pregnanc), was the
f i n a n c i a l  i m p l i c a t i o n s  o f  t h e
PreSnancy.
Misoprostol  produced a successful
medical induction of abortion in 95% of
cases with a maximum dose of 4 tablets,
and was almost 100% effective after a
second dose. This is extremely cost-
effective, because the surgical evacuation
could be done as a day theatre procedure,
suitable for a busy secondary hospital, a
district hospital or a community health
centre with surgical facilities. lt must be
remembered that this study focused on
first trimester abortions, which always
requires a surgical evacuation of the
uterus after an abortion, due to the
re lat ive ly  h igh chance of  reta ined
products of conception.
The use of Misoprostol was well accepted
by the patients.The majority had no or
only few minor side effects. None had to
stop the second intake of Misoprostol
due to intolerance.
Although there were 4 perforations of
uterus during evacuation (which had no
further complications), in general, the
procedure of using Misoprostol prior to
evacuation proved to be safe and effective.
The newer Manual Vacuum Aspiration
Device (MVA), which became available
in the hospital after completion of the
study, is softer than the olderVabra device
used in this study and reports about
decreased uterus per forat ions are
promising.
lf an induction has not been successful
with Misoprostol, an early ultrasound
investigation is warranted and possibility
of an ectopic pregnancy should be kept
in mind.
The poor compliance with the follow-
up visits in spite of the initial counselling
is a reason for concern and the underlying
reasons need to be addressed in further
studies. In addition to this the study
sample size may have been be too small
and the follow-up visit only one week
later  too soon to detect  la te
compl icat ions of  abor t ion,  such as
fee l i ngs  o f  gu i l t ,  dep ress ions  and
infertility.
The lack of contraceptive use before
conception and the lack ofarrangements
for family planing methods one week
afterTOP points to the need for further
education - on the primary care level
and possibly in school settings, as well
as the need for improved access to family
planning facilities in the community.
The intention of the new Abortion
law was to address the problem of
u n s a f e  a n d  i l l e g a l l y  p e r f o r m e d
backstreet  abor t ion of  unwanted
p regnanc ies ,  assoc ia ted  w i th  h igh
incidence of mortality and morbidity
for the women.To offer terminations
of  pregnancy f ree on demand in
facil i t ies designated by the Health
D e p a r t m e n t  m a y  r e d u c e  t h e
mortality and morbidity. With the
use of  Misoprosto l  the terminat ions
were ef fect ive,  safe and easy to
per form, promot ing i ts  use more
freely in future in South Africa.
Discussion
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